Daniel Meyer is Head of Statistics for the Rare Disease Therapeutic category for
Pfizer Global Product Development. He held previous group head roles at Pfizer
for infectious disease, cardiovascular & metabolic disease, and nonclinical
statistics. Dan received his PhD in Statistics from the University of
Wisconsin. He is a Fellow of the American Statistical Association.